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The functional role of suppressor cells in the control of the immune response 
has now been recognized. This phenomenon may soon be considered an essential 
aspect  of immunity.  The  role  of antigen-specific  and  nonspecific  suppressor 
lymphocytes in the regulation  of antibody production  has been demonstrated 
(1). In vivo experiments have suggested the existence of suppressor cells in some 
forms of immunologic tolerance  (2-5),  chronic suppression of alloantibody pro- 
duction (6, 7), antigenic competition (8), and lymphocyte response to stimulation 
by thymus-independent antigens such as pneumococcal polysaccharide S-III (9- 
11). 
Suppressor cells have also been shown to be involved in the control of cell- 
mediated  immunity  in  animals  (12).  Furthermore,  inhibition  of graft-versus- 
host reaction by suppressor cells has been demonstrated when thymocytes and 
spleen cells obtained from young NZB/W mice were transplanted  to newborn 
C3H/He mice (13,  14). 
Mouse spleen cells incubated in vitro with the plant lectin,  concanavalin  A 
(Con A), 1 will develop suppressor activity in several assay systems. These Con 
A-activated suppressor cells can inhibit in vitro lymphocyte response to sheep 
red blood cells (15, 16), allogeneic antigens in mixed lymphocyte cultures (MLC) 
(17),  and cell-mediated cytotoxicity (18). 
Recently, increasing  evidence has accumulated that suppressor cells in the 
peripheral  blood  may  be  involved  in  the  etiology and  pathogenesis  of such 
pathologic states as autoimmune disease in animals (14), and common variable 
hypogammaglobulinemia (19), Hodgkin's disease (20), and multiple myeloma in 
man (21). 
In this publication,  we report the existence of a population of cells present in 
the peripheral blood of healthy human volunteers which can be induced by Con 
A to manifest suppressor functions and that this potential may indeed reflect a 
latent immunologic control. 
Materials  and  Methods 
Isolation of Lymphocytes.  Lymphocytes were separated from fresh heparinized blood (20 U 
heparin per ml of blood) from healthy, volunteer adult donors by Ficoll-Hypaque density gradient 
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' Abbreviations  used  in  this  paper:  Con  A,  concanavalin  A;  HBSS,  Hanks'  balanced  salt 
solution; MC, mitomycin C; MLC, mixed lymphocyte culture; PHA, phytohemagglutinin-P; PPD, 
tuberculin purified protein derivative; PWM, pokeweed mitogen. 
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centrifugation using a  modification of the technique of B6yum  (22).  After washing three times 
with Ca ++- and  Mg++-free  Hanks' balanced salt solution  (HBSS,  Grand Island Biological  Co., 
Grand Island, N.  Y.) the cells were resuspended in RPMI 1640 medium (Grand Island Biological 
Co.)  containing  15%  heat-inactivated  pooled  human  serum  and  100  U  of penicillin,  50  g.g  of 
streptomycin,  and  2  /zmol of glutamine per ml  of medium  (RPMI).  The final suspension was 
adjusted to a concentration of either 5 x  10  ~ cells per mi for the mitogen and antigen stimulation 
studies or 1.0  x  10" responder lymphocytes per ml in the (MLC) reactions. 
Con A  Pretreatment ofLymphocytes.  A suspension of lymphocytes at a concentration of 3-5 × 
10" cells per ml of RPMI was cultured in the presence of Con A  (60 tLg/ml, Difco Laboratories, 
Detroit, Mich.) in a humidified, 5% CO~ incubator for 48 h. At the end of incubation, the cells were 
washed three additional times with HBSS and resuspended in RPMI at a  concentration equal to 
that of the responder lymphocytes. 
Cell Culture 
ONE-WAY MIXED LYMPHOCYTE CULTURE.  A 0.1-ml aliquot of responder cells was mixed with an 
equal volume of allogeneic,  Con A-pretreated lymphocytes in Microtest plate  (Falcon Plastics, 
Oxnard, Calif.). The cultures were incubated for 5 days in a  humidified 5% CO~ atmosphere. For 
the last 16 h  of incubation, 2 pCi of {aH]thymidine (New England Nuclear,  Boston, Mass.) were 
added to each well.  The cells were then collected with a  multiple automatic sample harvester. 
Incorporation of the isotope-labeled thymidine into lymphocytes was measured in a liquid scintil- 
lation counter using a  premixed scintillation cocktail  (Aquasol,  Packard Instrument Co.,  Inc., 
Downers Grove, Ill.). 
MITOGEN AND SPECIFIC ANTIGEN STIMULATION OF LYMPHOCYTES.  The preparation of lympho- 
cytes and cell culture conditions were as described above. Immediately after mixing the responder 
cells and the Con A, mitomycin C (MC)-pretreated iymphocytes, 25 ~1 of various concentrations of 
either one of the mitogens, phytohemagglutinin-P (PHA, 2.5/~l/m], Difco Laboratories), Con A (60 
pg/ml),  or pokeweed mitogen  (PWM,  20 pg/ml,  Difeo Laboratories); or the microbial antigens, 
tuberculin purified protein derivatives (PPD, Statens Seruminstitut, Copenhagen, Denmark), or 
Candida albicans  antigens prepared as described elsewhere (23)  were added to each of the wells 
and the cultures incubated for 5 days. 2 pCi of [3H]thymidine were added per well during the last 
16 h  of incubation. 
Experiments  with  both  MLC  and  mitogen  or  antigen-stimulated  cells  were  performed  in 
triplicate or quadruplicate.  The data are expressed as mean counts per minute per culture plus 
and minus the standard error of the mean. Percentage of blastogenic stimulation of responder cells 
inhibited by Con A-induced suppressor cells was calculated according to the following formula: 
(1  -  [(C~,  A -  C~A)/(C~  -  C)])  ×  100% equal to percentage of inhibition by Con A-induced sup- 
pressor cells, where: C',;2 is counts per minute of normal lymphocytes plus Con A, MC-pretreated 
cells plus mitogens, antigens, or allogeneic ceils; C '.4 is counts per minute of normal lymphocytes 
plus Con A, MC-pretreated cells; C,,, is counts per minute of normal lymphocytes plus MC-treated 
cells incubated without Con A plus mitogens, antigens, or allogeneic cells; C  is counts per minute 
of normal lymphocytes plus MC-treated cells incubated without Con A. 
Results 
Effect of Con A-Pretreated Lymphocytes on DNA Synthesis by Normal Hu- 
man Lymphocytes in Response to Mitogens.  As shown in Table I, the in vitro 
response of normal human lymphocytes to stimulation with PHA, Con A, and 
PWM was suppressed by allogeneic,  Con A-pretreated  lymphocytes, similarly 
obtained  from  healthy  adult  volunteer  donors.  Although  suppression  of the 
mitogenic  response  was  most  frequently  noted  when  allogeneic  Con  A-pre- 
treated normal donor cells were added to responder lymphocytes plus mitogen, 
other  activities  ranging  from  no  effect to  stimulation  were  occasionally  ob- 
served. Suppression, however, was most pronounced when Con A was used as a 
mitogen  and  occurred  to  a  lesser extent  when  PWM  was  used to  stimulate 
responder cells. It is emphasized that all blastogenic activity was attributable to 
untreated  responder  lymphocytes,  since  the  Con  A-induced  cells  had  been 1102  HUMAN  PERIPHERAL  BLOOD  SUPPRESSOR  CELLS 
TABLE  I 
Effect of Con A-Treated Allogeneic Lymphocytes on the Mitogenic Response of  Normal Human 
L  ymphocytes 
Respond-  Con A  [~H]TdR incorporation (cpm) in response to mitogens§ 
ing cells  pretreatment 
(sub-  of allogeneic  PHA  Con A  PWM 
jects)*  cells$ 
% in-  % in-  cpm  % in- 
cpm  hibition  cpm  hibition  hibition 
1  -  87,828  ±  6,684  121,521  ±  4,213  37,349  ±  369 
+  75,742  ±  5,566  13.8  88,444  ~  6,356  27.2  30,401  -+  2,897  18.6 
2  -  74,450  -~  3,270  65,035  ±  3,227  13,136  ±  354 
+  37,576  ±  653  49.5  34,945  ±  1,753  46.3  13,979  ±  1,026  +6.4 
3  -  126,324  ±  5,395  85,598  -+  2,878  44,285  ±  1,700 
+  90,479  ±  3,772  28.4  57,860  ±  519  32.4  27,285  ±  372  38.4 
4  -  73,138  ±  3,056  94,328  ±  3,366  15,583  ±  1,319 
+  59,999  ±  2,375  18.0  52,759  ±  1,717  44.1  15,312  ±  467  1.7 
5  -  38,650  ±  2,850  128,362  ±  6,229  11,445  ±  688 
+  28,215  ±  1,417  27.0  96,491  ±  1,266  24.8  18,493  ±  1,384  +61.6 
6  -  93,369  ±  930  188,524  ±  4,585  21,278  ±  629 
+  58,501  ±  2,903  37.3  117,377  ±  5,896  37.7  20,857  ±  1,521  2.0 
7  -  43,991  ±  3,244  125,332  ±  4,969  19,778  ±  2,068 
+  26,533  ±  392  39.7  69,036  ±  888  44.9  10,539  -+  713  46.7 
8  -  60,334  ±  6,856  146,836  ±  6,190  12,390  ~  515 
38,119  ±  554  36.8  73,787  ±  3,172  49.7  16,001  ±  835  +29.1 
* 5.0  x  104 normal donor lymphocytes were mixed with an equal number  of MC-treated allogeneic control or suppressor 
cells in RPMI plus designated mitogen and labeled with 2 t~Ci  [3H]thymidine ([3H]TdR) as described in Materials and 
Methods. Each pair of cultures consists of responder lymphocytes from a different subject donor. 
$ Allogeneic lymphocytes were incubated in RPMI plus or minus Con A  (60 ttg/ml) for 48 h. Cells were washed, treated 
with MC (50 t~g/ml) for 30 min, washed again, and resuspended in RPMI. 5.0  x  104 allogeneic cells were added to each 
culture well. 
§ Counts per minute of [~H}TdR incorporated represents the mean of 3-4 replicate cultures x  the standard error. 
previously treated with MC to prevent DNA synthesis. 
In these experiments, Con A-pretreated allogeneic lymphocytes functioned as 
suppressor cells.  To determine the amount of stimulation due to recognition of 
allogeneic lymphocyte-determined  antigens,  control cultures consisting of nor- 
mal lymphocytes and Con A-pretreated cells in the absence of exogenous mito- 
gens were set up concomitantly.  Considering the complicated reactions which 
may occur between  allogeneic  cells  in culture,  an autologous cell  system was 
developed and tested for suppressor activity.  In this syngeneic system, both the 
untreated responder lymphocytes and the Con A-pretreated cells came from the 
same individual. It is evident from the data in Table II that comparable suppres- 
sion of the mitogenic response can also be induced by Con A  with autologous 
cells. 
Effect of Con A  Pretreated Lymphocytes  on Blastogenic Transformation of 
Normal Lymphocytes  in Response to Specific Antigens.  To determine  if the 
Con  A-induced  suppressor  effect  was  active  on  the  lymphocyte  response  to 
naturally occurring microbial antigens as well as the nonspecific transformation 
elicited by mitogens,  cell  extracts of Candida albicans and PPD were used to LIEN  SHOU,  STANLEY  SCHWARTZ,  AND  ROBERT  GOOD 
TABLE II 
Effect of Con A  Treatment of Stimulator Lymphocytes  on the Allogeneic 




cells  pretreatment 
(subjects}*  of autologous 
cells~t 
{:~H]TdR  incorporation  {cpm) in response to mitogens§ 
PHA  Con A  PWM 
% in-  % in-  % in- 
cpm  hibition  cpm  hibition  cpm  hibition 
1  -  70,689  ±  4,855  98,718  -+  5,369  20,961  ±  497 
+  38,928  ±  1,537  44.9  48,788  ±  739  50.6  15,455  ±  618  26.3 
2  -  39,543  ±  4,542  153,725  ±  1,534  7,152  ±  85 
+  23,326  ±  1,236  41.0  135,043  ±  5,640  12.1  13,751  -+  363  +92.3 
3  108,413  -+  6,667  220,224 ±  20,875  18,780  ±  912 
+  85,620 +- 3,614  21.0  160,887  ±  10,320  26.9  17,663  -+  490  5.9 
4  -  114,344  ±  1,885  177,377  +  13,284  14,636  ±  608 
+  118,566  ±  2,200  +3.7  172,470  _+  9,287  2.8  13,974  ±  860  4.5 
5  65,390  ±  3,006  170,293  ±  7,138  15,683  -+ 343 
+  53,357  ±  3,206  18.4  146.380  ±  2,261  14.0  16,411  ±  684  +3.3 
6  68,802 ±  2,356  187,398  +-  4,017  25,188  -+ 769 
+  47,169  -+  1,150  31.4  154,919  ±  2,930  17.3  20,938  ±  346  16.9 
* 5.0 × 10  ~ normal donor lymphocytes were mixed with an equal number of MC-treated autologous control or suppressor 
cells. Other conditions as in legend to Table I. 
$ 5.0 × 104 lymphocytes were treated as in the legend for Table I, and were added to freshly prepared autologous normal 
donor lymphocytes. 
§ Same as in legend for Table I. 
stimulate lymphocytes in the microtest technique as described in Materials and 
Methods. The data in Table III demonstrate  the suppressor activity of Con A- 
pretreated lymphocytes on the blastogenic response of normal allogeneic cells to 
these microbial antigens.  Attention is drawn to the fact that all responder cells 
were stimulated by either the antigens alone or by the allogeneic mitomycin C- 
treated lymphocytes used for Con A induction of suppressor activity. Inhibition 
of the transformation  response was noted only when the mitomycin C-treated 
allogeneic cells had also been pretreated with Con A. When autologous lympho- 
cytes were pretreated  with  Con A  and added to cultures of normal  responder 
cells plus mitogen, a  suppressor effect similar to that manifested in the alloge- 
neic systems was also observed (Table IV).  Untreated responding lymphocytes 
underwent blastogenesis in the presence of the antigens as previously indicated; 
however, no stimulatory effect was noted when mitomycin C-treated lympho- 
cytes were mixed with normal, untreated autologous cells. These latter data a÷e 
not presented. 
Suppression of Allogeneic Stimulation of Responder Cells in MLC by Con A- 
pretreated Lymphocytes.  The  most impressive  and  consistent suppression of 
lymphocyte response was observed when Con A-pretreated allogeneic cells were 
incubated  in  the  one-way MLC.  As evidenced in  Table V,  when  Con A-pre- 
treated  allogeneic  cells are  used  as stimulators,  blast  transformation  by re- 
sponder lymphocytes is markedly inhibited. To determine whether this phenom- 
enon was attributable  to an active suppressor mechanism  or to a  decrease in 1104  HUMAN  PERIPHERAL  BLOOD  SUPPRESSOR  CELLS 
TABLE  III 
Effect of Con-A-Treated Allogeneic Lymphocytes on Blast Transformation by Normal 
Human Lymphocytes in Response to Antigens 
Respond-  Con A pre-  [3H]TdR incorporation (cpm) in response to antigens§ 
ing cells  treatment 
(sub-  of alloge-  PPD  Candida 
jects)*  neic cells$ 
%  inhibi-  %  inhibi- 
cpm  tion  cprn  tion 
1  -  100,547  ±  6,876  48,994 ±  6,807 
+  24,168  ±  4,115  76.0  20,450  -+  1,607  58.3 
2  -  17,644  -+  913  13,660  ±  897 
+  2,947  ±  970  83.3  2,956  _+  644  78.4 
3  -  48,519  -+  8,116  19,866  _  4,944 
+  23,333  -+  558  51.9  14,018  ±  2,607  29.4 
* 5.0 x  104 normal donor lymphocytes were mixed with an equal number of MC-treated allogeneic 
control or suppressor cells in RPMI plus the designated antigen.  Other conditions as in legend 
for Table I. 
Same as in legend for Table I. 
§ Same as in legend for Table I. 
effective alloantigenicity through induced loss or masking of alloantigens as 
with steric hindrance, a  syngeneic suppressor cell system was devised. Under 
these conditions, both the responder and suppressor lymphocytes are obtained 
from the same individual. Table  VI  shows that in all individuals tested the 
allogeneic response is suppressed when homologous Con A-pretreated cells are 
added to  the  MLC.  Furthermore,  control cultures consisting of lymphocytes 
homologous to responder cells preincubated in the absence of Con A but treated 
with mitomycin C  and likewise added to MLC's showed no suppression and 
occasionally had an enhancing effect. With regard to the latter, all standard 
control  MLC's demonstrated appropriate  allogeneic responses.  In  every case 
when lymphocytes  obtained from normal donors were left untreated, no suppres- 
sion of mixed leukocyte culture responses was noted. 
Discussion 
It is becoming increasingly evident that the immune system requires checks 
and balances to prevent an excessive reaction by any individual element to the 
multitude of stimulations experienced throughout the lifetime of the organism. 
Suppressor cells have been proposed as one mechanism that can modulate an 
immune response. Evidence to date suggests a role for suppressor lymphocytes 
in the pathogenesis of several disease states in man (19-21);  however, others 
have postulated that suppressor cells are but one of a  diverse array of control 
mechanisms responsible for modulating the normal immune system (1). Thus 
one would expect such suppressor cells also to be present in most individuals. 
As has been shown by others using cells from immunologically  active tissues 
in animals, mitogenic doses of Con A can activate lymphocytes, which subse- LIEN  SHOU,  STANLEY  SCHWARTZ,  AND  ROBERT  GOOD  1105 
TABLE  IV 
Effect of Con A-Treated Autologous Lymphocytes on Blast Transformation  by Normal 
Human Lymphocytes in Response to Antigens 
Respond-  Con A  pre- 
ing cells  treatment 
(sub-  of autolo- 
jects)*  gous cells$ 
[:*H]TdR incorporation  Icpm) in response to antigens§ 
PPD  Candida 
-  36,617  ±  3,807 
+  26,473  ±  2,239 
2  -  69,313  ±  4,895 
+  29,741  ±  1,238 
%inhibi-  % inhibi- 
cpm  tion  cpm  tion 
63,384  ±  6,279 
27.7  27,275  ±  1,782  57.0 
31,188  ±  1,685 
57.1  13,364  ±  2,062  57.1 
3  -  34,234  ±  1,929  32,491  ±  920 
+  18,651  ±  664  45.5  15,740 ±  820  51.6 
* 5.0 x  10  ~ normal donor lymphocytes were mixed with an equal number of MC-treated autologous 
control or suppressor cells in RPMI plus the designated antigen.  Other conditions as in legend 
for Table I. 
$ 5.0  ×  10  ~ lymphocytes were treated as in legend for Table I and were added to freshly prepared 
autologous normal donor lymphocytes. 
§ Same as in legend for Table I. 
quently inhibit  antibody secretion  in vitro  (15,  16); this  effect can be demon- 
strated to be exclusive of cytotoxicity (24). Thomas et al.  (25) suggest that such 
inhibitory or suppressor activity may be due to an antimitotic effect and further 
propose  that  such  mechanisms  may be responsible  for  inhibiting  tumor  cell 
proliferation.  By contrast to the animal  studies where cells were derived from 
central  immune  tissues,  the  present  investigations  demonstrate  that  similar 
suppressor  cells can  be induced  by Con  A  treatment  of the  peripheral  blood 
lymphocytes of healthy adult humans. These suppressor cells can also be shown 
to exert antimitotic effects. Furthermore, unlike the animal models presented to 
date,  where  inhibition  of blastogenesis  required  preliminary  sensitization  of 
responder cells in vitro, the suppressor cells described in these studies are active 
on  lymphocytes responding  to  proliferate  to  de  novo  stimuli  in  experiments 
employing  mitogens,  antigens,  or  allogeneic  cells.  As  a  final  contrast,  the 
animal  studies  utilized  inhibition  of a  B-cell function,  antibody  secretion  as 
an  indicator of suppressor activity.  Since blastogenesis with nonspecific mito- 
gens such as PHA, Con A, and PWM can involve either B or T lymphocytes, in 
several  instances,  the degree of suppression  noted was greater than  could be 
attributed solely to inhibition of B-cell responses.  We conclude, therefore, that 
the suppressor effect described may be a phenomenon of more general influence 
involving  both  major  lymphocyte subclasses.  From  the  data  presented,  it  is 
possible  that  the  effects observed could  be  attributed  to  inhibition  of T-cell 
proliferation alone. Our results do not distinguish between these two possibili- 
ties. The latter alternative receives support from the observation that suppres- 
sion of the response to PWM, a potent B-cell stimulator, was generally less than 
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TABLE  V 
Effect of Con A  Treatment of Stimulator Lymphocytes on the AUogeneic 
Response of Normal Human Lymphocytes 
Responding  Con A pre- 
treatment of  Percent of inhi-  cells (sub-  cpm§ 
jects)*  allogeneic  bition 
cells$ 
1  -  6,517  _+ 226 
+  1,879  _+  134  71.2 
2  -  5,613  -+ 339 
+  3,169 _+  176  43.5 
3  -  3,144  _+ 364 
+  1,814 +_ 6  42.3 
4  -  8,843 _+ 553 
+  1,974 _+ 89  77.7 
5  -  8,846  _+ 834 
+  6,721  _+ 283  24.0 
6  -  13,142 _+ 603 
+  7,252 +_ 23  44.8 
7  -  26,787 +_ 1,059 
+  16,207 _+ 572  39.5 
* 1.0. x  10:' normal donor lymphocytes were mixed with an equal number of MC- 
treated allogeneic ceils in a one-way MLC as described in Methods. Other condi- 
tions as in legend for Table I. 
$ 1.0 x  10:' lymphocytes were treated with or without Con A as in legend for Table I 
and were added to an equal number of freshly prepared allogeneic normal donor 
lymphocytes. 
§ Same as in legend for Table I. 
The  postulated  existence of suppressor cells capable of modulating  immune 
reactivity in all individuals was further supported by demonstrating  that  lym- 
phocytes could be induced to inhibit proliferative responses by autologous cells. 
Such  observations  are  consistent  with  a  model  that  proposes  that  individual 
stimuli are prevented from initiating an unchecked immunologic chain reaction 
in vivo through  the  intervention  of suppressor cells capable of abrogating  the 
response.  Furthermore,  the induction of suppressor cells in an entirely autolo- 
gous  system  obviates the  need  to  invoke  the  nonspecific allotype suppression 
proposed by Jacobson  (26). 
Since  we  would  define  this  form  of suppression  as  a  reversible  inhibition 
which does not  result  in cell death,  trypan  blue dye exclusion analysis of our 
cells at  the  termination  of incubation  revealed  greater  than  95%  viability in 
either  autologous  or  allogeneic cultures.  Several  lymphocyte  stimulators,  in- 
cluding PHA,  allogeneic and xenogeneic antigens, and specific cellular antibod- 
ies can  elicit immunospecific  cytotoxicity (27).  However,  Perlmann  et al.  (24) 
have shown that Con A  not only fails to generate  such cytotoxicity when human LIEN  SHOU,  STANLEY  SCHWARTZ,  AND  ROBERT  GOOD  1107 
TABLE VI 
Suppression of the Allogeneic Response of Normal L  ymphocytes by Con A-Pretreated 
Autologous Cells 
Respond-  Stimulat-  Suppressor cells§  Percent 
ing cells  ing cells  cpm  inhibi- 






























-  AGm  -  555  -+  44 
AKIn  -  -  18,238  +-  2,070 
AKIn  AGm  Medium alone  19,056  _+  1,124 
AKIn  AGm  Con A  12,140  _+  1,328  36.3 
-  MBm  -  1,016  -  110 
AKIn  -  -  14,801  -+  982 
AKIn  MBm  Medium alone  20,972  _+  657 
AKIn  MBm  Con A  12,919  +-  1,627  38.4 
-  GOm  -  626  -+  83 
AKm  -  -  18,665  _  1,154 
AKm  GOre  Medium alone  20,850  _+  1,510 
AKIn  GOre  Con A  15,603  _  934  25.2 
-  LCm  -  3,939  -+  436 
AKIn  -  -  20,537  _+  726 
AKIn  LCm  Medium alone  20,211  _+  1,270 
AKIn  LCm  Con A  10,577  -  989  47.7 
-  SSm  -  655  -+  38 
VMm  -  -  34,461  +-  698 
VMm  SSm  Medium alone  37,455 _ 1,175 
VMm  SSm  Con A  28,708  _+  1,406  23.4 
-  MCm  -  680  -+  73 
VMm  -  -  29,086  _+  1,428 
VMm  MCm  Medium alone  34,213  _+  1,535 
VMm  MCm  Con A  16,878  -+  1,988  50.7 
-  EHm  -  1,346  -+  85 
VMm  -  -  48,369  _+  2,371 
VMm  EHm  Medium alone  47,888  _  988 
VMm  EHm  Con A  37,692  -+  1,107  21.3 
as in legend for Table V. 
1.0 × 103  MC-treated (designated  by subscript "m") lymphocytes were added to an equal number 
of  freshly prepared allogeneic normal donor cells. 
§ An additional 1.0 ×  105 MC-treated lymphocytes autologous to the untreated responder cells 
previously incubated for 48 h with or without Con A  were added to each MLC  as indicated. 
§ Same as in legend for Table I. 
peripheral blood lymphocyte  proliferation is stimulated, but can even inhibit the 
PHA-induced cytotoxic effect. This may be taken as additional evidence that 
Con A induces a suppressor influence which can operate under several different 
circumstances. 
Throughout the studies we observed occasional individuals whose lyrnpho- 
cytes did not manifest suppressor  activity after Con A  treatment  (Table  II, 
subject no. 4). This failure is not attributable to the absence of receptors for Con 
A, since the cells transformed well in response to the mitegen. It is possible that 
Con A  can act through more than a  single receptor; one site responsible for 
triggering blast transformation and another for initiating suppressor activity. 
Thus,  cells that cannot be  induced to manifest suppressor functions, but can 1108  HUMAN  PERIPHERAL  BLOOD  SUPPRESSOR  CELLS 
undergo  blast  transformation,  may lack  a  second  receptor.  Such  individuals 
may have a  diminished  potential  suppressor cell population as occurs later in 
the NZB/W mouse (14) and consequently might be increasingly  susceptible to 
autoimmune disease. The variability in the degree of inducible suppression from 
person  to person and  in  the  same  individual  at various times  (data not pre- 
sented) probably reflects the state of immunologic reactivity at that moment. 
That is, few suppressor cells would be required or expected early in an immune 
response, but later a greater suppressor activity would be necessary to prevent 
immunologic excesses. 
Since we have shown that Con A can induce a suppressor response of autolo- 
gous cells,  the total amount of blast transformation  observed ai~r treatment 
with this  mitogen might  not reflect the full proliferative potential  of the cell 
population.  Indeed, if suppressor cells were selectively removed from a  suspen- 
sion of lymphocytes, one might observe an even greater mitogenic effect with 
equivalent amounts of Con A. 
Of major importance is the establishment of the molecular mechanism of the 
Con A-induced suppressor effect reported here. Search for a soluble mediator for 
suppression of human lymphoid cells like that demonstrated in several animal 
studies (25, 28) is necessary as are experiments to determine whether direct cell- 
cell contact is needed for this influence. Recent investigations by other workers 
have raised the possibility that latent viruses induced by immunologic stimuli 
such as mitogens, in particular Con A, and allogenic responses may contribute 
to immunosuppression (29). It is therefore possible that Con A could be acting by 
activation of latent intracellular viruses with concomitant immunosuppressive 
effects. If so, such a virus or viruses are widely distributed in the blood cells of 
healthy men. 
It is tempting to conclude that the presence of cells capable, upon appropriate 
stimulation,  of manifesting  immune  suppression  in  the  peripheral  blood of 
healthy  adults  probably  represents  a  normal  control  mechanism  which  can 
contribute to immunologic homeostasis and stability. An analysis of variations 
of such suppressor cells during ontogeny, aging,  and disease seems urgent. 
Summary 
Pretreatment of normal human peripheral blood lymphocytes with the plant 
lectin, concanavalin A (Con A), results in inhibition of blast transformation and 
[:~H]thymidine incorporation by untreated allogeneic lymphocytes from healthy 
volunteer donors in one-way mixed leukocyte culture.  Similarly,  responses to 
mitogens, certain microbial antigens, and allogeneic lymphocytes are inhibited 
by Con A-treated.  allogeneic cells.  Con A  pretreated  autelogous lymphocytes 
can  also be induced to manifest  suppressor activities.  This  antimitotic  effect 
occurs without evidence of cytotoxicity and  is  active  on de  novo  lymphocyte 
responses and does not require prior sensitization of the cells being tested. 
Suppression of the lymphocyte response to pokeweed mitogen, a potent B-cell 
stimulator,  by Con A-pretreated suppressor cells was not as consistent as was 
inhibition  of response  to  other  mitogens,  including  phytohemagglutinin  and 
Con A. Furthermore, suppression of lymphocyte transformation to the microbial 
antigens, tuberculin purified protein derivative, and Candida albicans extracts LIEN  SHOU,  STANLEY  SCHWARTZ,  AND  ROBERT  GOOD  1109 
could  be  similarly  induced  by  Con  A  pretreatment  of either  allogeneic  or 
autologous cells. 
Induction  of autologous  suppressor  activity  in  lymphocytes  from  healthy 
donors is compatible with a model that includes a role for suppressor cells in the 
modulation of the normal immune response. 
Received for publication 3 February 1976. 
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